Abstract
Expression of CD95, a molecule involved in activation-induced cell death (AICD), might contribute to explain accumulation of leukemic B-cells and functional impairment of T-cells in B-cell chronic lymphocytic leukemia (B-CLL). There-fore, we compared constitutive and activation-induced expression of CD95 and CD69 by B- and T-cells in CLL patients and in healthy donors.
Vol. 87 No. 3 (2002): March, 2002 : Letters to the Editor
Published By
Ferrata Storti Foundation, Pavia, Italy
